SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABR Information Services (ABRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vegas who wrote (121)11/25/1998 5:04:00 PM
From: Jim Mac  Read Replies (1) of 156
 
Recent EPS was artificially high due to non-recurring lease revenues, and lower tax rate.

Recent acquisitions won't add to earnings any time soon, according to ABR's own press releases.

Since ABRX is still way down from its overvalued highs earlier this year, tax-selling season kicking in now, and ABRX moderately priced, not eye-popping cheap, I won't be surprised if ABRX dips down near $10 again by year end.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News